Patient
SITE012-0015
completed Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE012 (BRA) (Dr. Kowalski)
consented 2025-09-06
Adverse events
7
Serious AEs
1
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 7
Grade 3 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-09-04 (study day 170); relationship: not assessed
Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-09-02 (study day 168); relationship: not assessed
Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-08-16 (study day 151); relationship: not assessed
Grade 3 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-07-04 (study day 108); relationship: not assessed
Grade 4 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-06-20 (study day 94); relationship: NOT RELATED; serious criteria: life-threatening
Grade 3 Constipation — outcome: RECOVERED/RESOLVED; onset 2022-05-12 (study day 55); relationship: NOT RELATED
Grade 2 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-03-22 (study day 4); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.